ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,949,774 | -34.6% | 3,132,194 | -16.1% | 0.00% | 0.0% |
| Q2 2023 | $28,962,244 | -36.6% | 3,732,248 | -53.4% | 0.00% | 0.0% |
| Q1 2023 | $45,680,930 | +93.1% | 8,014,198 | +99.5% | 0.00% | 0.0% |
| Q4 2022 | $23,657,822 | +70.0% | 4,016,608 | -7.6% | 0.00% | +100.0% |
| Q3 2022 | $13,915,000 | -28.7% | 4,348,392 | -0.2% | 0.00% | -50.0% |
| Q2 2022 | $19,512,000 | -17.3% | 4,355,182 | -1.4% | 0.00% | 0.0% |
| Q1 2022 | $23,594,000 | -72.8% | 4,418,413 | -25.2% | 0.00% | -66.7% |
| Q4 2021 | $86,837,000 | -29.6% | 5,907,279 | +0.2% | 0.01% | -40.0% |
| Q3 2021 | $123,320,000 | +26.6% | 5,897,652 | +7.1% | 0.01% | +25.0% |
| Q2 2021 | $97,372,000 | -27.8% | 5,504,372 | +0.0% | 0.01% | -33.3% |
| Q1 2021 | $134,854,000 | -26.9% | 5,504,252 | +1.0% | 0.01% | -25.0% |
| Q4 2020 | $184,562,000 | +65.9% | 5,452,347 | +21.3% | 0.02% | +45.5% |
| Q3 2020 | $111,226,000 | -19.9% | 4,493,328 | +6.8% | 0.01% | -26.7% |
| Q2 2020 | $138,794,000 | – | 4,206,948 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |